• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年糖尿病患者胰岛素治疗的特殊注意事项。

Special considerations with insulin therapy in older adults with diabetes mellitus.

机构信息

Department of Medicine, University of Florida College of Medicine, Jacksonville, USA.

出版信息

Drugs Aging. 2011 Jun 1;28(6):429-38. doi: 10.2165/11590570-000000000-00000.

DOI:10.2165/11590570-000000000-00000
PMID:21639404
Abstract

Aging is associated with alterations in insulin secretion and action. However, aging per se does not alter the pharmacokinetics of commercially available insulin and its analogues. Insulin therapy in older adults is complicated by psychosocial and physiological changes of aging. Several new insulin and insulin analogue preparations are now available for clinical use. Used as prandial (e.g. insulin lispro, insulin aspart or insulin glulisine) and basal insulin (e.g. insulin glargine, insulin detemir), these analogues simulate physiological insulin profiles more closely than the older conventional insulins. The availability of multiple insulin products provides new opportunities to achieve control of diabetes mellitus. The choice of initial insulin therapy can be made based on blood glucose profiles. Overall, these profiles can be divided into three general patterns that include: (i) round-the-clock hyperglycaemia; (ii) fasting hyperglycaemia with daytime euglycaemia; and (iii) daytime hyperglycaemia with normal fasting blood glucose levels. The prescription of insulin is a dynamic process, and the insulin regimen should be adjusted based on individual response. The goal of diabetes care in older adults is to enhance quality of life without subjecting individuals to complicated treatment regimens that may interfere with their independence in carrying out daily activities.

摘要

衰老是与胰岛素分泌和作用的改变有关。然而,衰老本身并不会改变市售胰岛素及其类似物的药代动力学。老年人的胰岛素治疗受到衰老的心理社会和生理变化的影响。目前有几种新的胰岛素和胰岛素类似物制剂可供临床使用。这些类似物可作为餐时(如胰岛素赖脯、胰岛素门冬或胰岛素谷赖)和基础胰岛素(如甘精胰岛素、地特胰岛素)使用,与较老的常规胰岛素相比,它们更能模拟生理胰岛素谱。多种胰岛素产品的出现为控制糖尿病提供了新的机会。初始胰岛素治疗的选择可以根据血糖谱来进行。总的来说,这些图谱可以分为三种一般模式,包括:(i)全天高血糖;(ii)白天血糖正常但空腹高血糖;和(iii)白天高血糖但空腹血糖水平正常。胰岛素的处方是一个动态的过程,应根据个体反应调整胰岛素方案。老年人糖尿病治疗的目标是提高生活质量,而不会使个体承受可能干扰其进行日常活动独立性的复杂治疗方案。

相似文献

1
Special considerations with insulin therapy in older adults with diabetes mellitus.老年糖尿病患者胰岛素治疗的特殊注意事项。
Drugs Aging. 2011 Jun 1;28(6):429-38. doi: 10.2165/11590570-000000000-00000.
2
Narrative review: a rational approach to starting insulin therapy.叙述性综述:启动胰岛素治疗的合理方法。
Ann Intern Med. 2006 Jul 18;145(2):125-34. doi: 10.7326/0003-4819-145-2-200607180-00010.
3
Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus.胰岛素类似物与人类胰岛素在糖尿病治疗中的优越性。
Arch Physiol Biochem. 2008 Feb;114(1):3-10. doi: 10.1080/13813450801900777.
4
Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.餐时预混胰岛素类似物方案与基础胰岛素类似物方案治疗2型糖尿病的循证比较
Clin Ther. 2007;29 Spec No:1254-70.
5
New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.新型胰岛素类似物与给药途径:药效学及临床考量
Clin Pharmacokinet. 2008;47(9):595-610. doi: 10.2165/00003088-200847090-00003.
6
Role of ultrafast-acting insulin analogues in the management of diabetes.超短效胰岛素类似物在糖尿病管理中的作用。
J Am Assoc Nurse Pract. 2019 Sep;31(9):537-548. doi: 10.1097/JXX.0000000000000261.
7
Insulin analogues in the management of diabetes.胰岛素类似物在糖尿病管理中的应用
Methods Find Exp Clin Pharmacol. 2004 Jul-Aug;26(6):445-61.
8
Insulin glargine (Lantus).甘精胰岛素(来得时)。
Int J Clin Pract. 2002 Jul-Aug;56(6):460-6.
9
[Insulin therapy].[胰岛素治疗]
Minerva Endocrinol. 2001 Jun;26(2):65-86.
10
A critical appraisal of the role of insulin analogues in the management of diabetes mellitus.对胰岛素类似物在糖尿病管理中作用的批判性评估。
Drugs. 2005;65(3):325-40. doi: 10.2165/00003495-200565030-00003.

引用本文的文献

1
Effectiveness of a Community Health Worker-Led Diabetes Intervention among Older and Younger Latino Participants: Results from a Randomized Controlled Trial.社区卫生工作者主导的糖尿病干预措施在老年和年轻拉丁裔参与者中的效果:一项随机对照试验的结果
Geriatrics (Basel). 2018 Sep;3(3). doi: 10.3390/geriatrics3030047. Epub 2018 Aug 2.
2
Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.速效胰岛素类似物在1型糖尿病或妊娠期糖尿病特殊人群中的疗效与安全性:系统评价与荟萃分析
Diabetes Ther. 2018 Jun;9(3):891-917. doi: 10.1007/s13300-018-0411-7. Epub 2018 Apr 5.
3

本文引用的文献

1
Insulin detemir is not transported across the blood-brain barrier.德谷胰岛素不能透过血脑屏障转运。
Peptides. 2010 Dec;31(12):2284-8. doi: 10.1016/j.peptides.2010.09.011. Epub 2010 Sep 22.
2
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients.胰岛素及其类似物的剂量与胰岛素治疗的 2 型糖尿病患者的癌症发生情况。
Diabetes Care. 2010 Sep;33(9):1997-2003. doi: 10.2337/dc10-0476. Epub 2010 Jun 14.
3
Pathophysiology of diabetes in elderly people.老年人糖尿病的病理生理学
Similar Efficacy and Safety of Basaglar and Lantus in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study.
在2型糖尿病患者中(年龄组<65岁、≥65岁),Basaglar和来得时的疗效与安全性相似:来自ELEMENT-2研究的事后分析
Diabetes Ther. 2018 Apr;9(2):827-837. doi: 10.1007/s13300-018-0405-5. Epub 2018 Mar 14.
4
Diabetes and altered glucose metabolism with aging.糖尿病与衰老时葡萄糖代谢的改变。
Endocrinol Metab Clin North Am. 2013 Jun;42(2):333-47. doi: 10.1016/j.ecl.2013.02.010. Epub 2013 Mar 22.
5
Observational study of once-daily insulin detemir in people with type 2 diabetes aged 75 years or older: a sub-analysis of data from the Study of Once daily LeVEmir (SOLVE).观察性研究:每日一次地特胰岛素在 75 岁及以上 2 型糖尿病患者中的应用:来自每日一次 Levemir 疗效研究(SOLVE)数据的亚分析。
Drugs Aging. 2013 Mar;30(3):167-75. doi: 10.1007/s40266-013-0054-3.
Acta Biomed. 2010;81 Suppl 1:47-53.
4
Incretin-based therapies for type 2 diabetes mellitus: current status and future prospects.基于肠降血糖素的 2 型糖尿病治疗药物:现状与展望。
Pharmacotherapy. 2010 Jun;30(6):609-24. doi: 10.1592/phco.30.6.609.
5
Self-monitoring of blood glucose in type 2 diabetes: systematic review.2 型糖尿病的自我血糖监测:系统评价。
Health Technol Assess. 2010 Mar;14(12):1-140. doi: 10.3310/hta14120.
6
Antidiabetic oral treatment in older people: does frailty matter?老年人的抗糖尿病口服治疗:虚弱是否重要?
Drugs Aging. 2009 Dec;26 Suppl 1:53-62. doi: 10.2165/11534660-000000000-00000.
7
Diagnosis and classification of diabetes mellitus.糖尿病的诊断与分类
Diabetes Care. 2010 Jan;33 Suppl 1(Suppl 1):S62-9. doi: 10.2337/dc10-S062.
8
Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes.普兰林肽作为1型和2型糖尿病辅助治疗的综述。
Drug Des Devel Ther. 2009 Feb 6;2:203-14. doi: 10.2147/dddt.s3225.
9
Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.在 2 型糖尿病成人患者中停止使用和重新使用吸入型人胰岛素(exubera)治疗的安全性和有效性:一项为期 3 年的随机对照试验。
Diabetes Technol Ther. 2009 Nov;11(11):697-705. doi: 10.1089/dia.2009.0062.
10
Review of clinical trials: update on oral insulin spray formulation.临床试验综述:口服胰岛素喷雾制剂的最新进展。
Diabetes Obes Metab. 2010 Feb;12(2):91-6. doi: 10.1111/j.1463-1326.2009.01127.x. Epub 2009 Nov 2.